Critical ischemia in the lower limbs: Frequent Readmissions show the magnitude of this problem

Critical Ischemia in the Lower Limbs: Frequent Readmissions Show the Magnitude of This ProblemReadmissions at 6 months in patients with critical ischemia in the lower limbs occur in about 50% of all cases and most of them are unplanned.

 

This truly alarming number is cause for further concern when taking into account that only part of these readmissions are related to vascular problems. Many are caused by comorbidities such as infection or diabetes, often related to critical ischemia.

 

What this work does not say, ultimately, is that revascularization of the affected limb is not enough: physicians must ensure that all comorbidities are being properly treated.

 

In order to obtain the included data, 212,241 patients with critical ischemia in the lower limbs treated between 2009 and 2013 were analyzed.

 

At 30 days and 6 months, all-cause readmissions were 27.1% and 56.6%, respectively. Almost a fourth of all 30-day readmissions and almost half of all 6-month readmissions were unplanned.

 

A third of all unplanned readmissions were mainly due to causes related to critical ischemia or post-procedural complications, while the rest of them were a result of non-vascular causes such as sepsis or diabetes.

 

Patients who underwent surgical revascularization during index hospitalization were more prone to readmission than those revascularized endovascularly.

 

A more prolonged length of stay during index hospitalization was directly associated with the likelihood of readmission, which was, in turn, associated with higher mortality rates. A longer stay during index hospitalization could be explained simply as a result of patients who are more ill and, in turn, more likely to be readmitted. This should be a fairly simple way of predicting which patients require a closer follow-up in order to prevent unplanned readmissions.

 

Conclusion

Readmissions among patients with critical ischemia in the lower limbs are very frequent and most of them unplanned. A high number of demographic, clinical, and socioeconomic factors may play important roles in predicting these events.

 

Original title: Burden of Readmissions Among Patients with Critical Limb Ischemia.

Reference: Agarwal S et al. J Am Coll Cardiol. 2017; 69:1897-1908.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...